Compounds > oxazoles
Page last updated: 2024-08-21

oxazoles and gsk598809

oxazoles has been researched along with gsk598809 in 4 studies

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's4 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bani, M; Beaver, JD; Comley, RA; Griffante, C; Gunn, R; Houle, S; Laruelle, M; Merlo-Pich, E; Mugnaini, M; Rabiner, EA; Searle, G; Slifstein, M; Tziortzi, A; Wilson, AA1
Bani, M; Bargiela, D; Beaver, JD; Colasanti, A; Erritzoe, D; Gunn, RN; Lingford-Hughes, A; Merlo-Pich, E; Nutt, DJ; Rabiner, EA; Searle, GE; Tziortzi, A; Waldman, A1
Acri, JB; Appel, NM; Holmes, TH; Li, SH1
Boyapati, V; Deakin, JF; Elliott, R; Ersche, KD; Flechais, R; Kuchibatla, S; Lingford-Hughes, A; McGonigle, J; Metastasio, A; Murphy, A; Nestor, LJ; Nutt, DJ; Orban, C; Passetti, F; Paterson, L; Reed, L; Robbins, TW; Smith, D; Suckling, J; Taylor, E1

Other Studies

4 other study(ies) available for oxazoles and gsk598809

ArticleYear
Imaging dopamine D3 receptors in the human brain with positron emission tomography, [11C]PHNO, and a selective D3 receptor antagonist.
    Biological psychiatry, 2010, Aug-15, Volume: 68, Issue:4

    Topics: Adult; Azabicyclo Compounds; Binding, Competitive; Brain; Brain Mapping; Carbon Radioisotopes; Dopamine Agonists; Dopamine Antagonists; Dose-Response Relationship, Drug; Humans; Oxadiazoles; Oxazines; Oxazoles; Positron-Emission Tomography; Receptors, Dopamine D3; Tissue Distribution

2010
In vivo imaging of cerebral dopamine D3 receptors in alcoholism.
    Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology, 2014, Volume: 39, Issue:7

    Topics: Adult; Age Factors; Alcoholism; Azabicyclo Compounds; Cerebral Cortex; Dopamine Antagonists; Female; Humans; Male; Middle Aged; Oxazines; Oxazoles; Positron-Emission Tomography; Protein Binding; Psychiatric Status Rating Scales; Receptors, Dopamine D3; Smoking; Young Adult

2014
Dopamine D3 Receptor Antagonist (GSK598809) Potentiates the Hypertensive Effects of Cocaine in Conscious, Freely-Moving Dogs.
    The Journal of pharmacology and experimental therapeutics, 2015, Volume: 354, Issue:3

    Topics: Animals; Azabicyclo Compounds; Behavior, Addictive; Blood Pressure; Cardiovascular Diseases; Cocaine; Cocaine-Related Disorders; Dogs; Dopamine Antagonists; Male; Oxazoles; Receptors, Dopamine D3

2015
Acute D3 Antagonist GSK598809 Selectively Enhances Neural Response During Monetary Reward Anticipation in Drug and Alcohol Dependence.
    Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology, 2017, Volume: 42, Issue:5

    Topics: Adult; Alcoholism; Anticipation, Psychological; Azabicyclo Compounds; Brain; Brain Mapping; Double-Blind Method; Female; Humans; Inhibition, Psychological; Magnetic Resonance Imaging; Male; Middle Aged; Oxazoles; Receptors, Dopamine D3; Reward; Substance-Related Disorders; Young Adult

2017